For the Inventor, By the Inventor

Enter assignee name

Hyderabad Telangana, India

Natco Pharma Limited

USPTO Granted Patents = 51

% Expired Patents = 27.5

CIPO Patents = 2

EPO Patents = 19

Forward Citations = 50

Loading Chart...

Loading Chart...

93 inventors (with patents filed for the assignee):

Venkaiah Chowdary Nannapaneni (28 out of 28 patents)

Nannapaneni Venkaiah Chowdary (22 out of 22 patents)

Bhujanga Rao Adibhatla Kali Satya (16 out of 16 patents)

4. Durga Prasad Konakanchi (14 out of 15 patents)

5. Pulla Reddy Muddasani (12 out of 12 patents)

6. Kali Satya Bhujanga Rao Adibhatla (11 out of 11 patents)

7. Amala Kompella (10 out of 10 patents)

8. Sreenivas Rachakonda (10 out of 10 patents)

9. Ramanadham Jyothi Prasad (8 out of 8 patents)

10. Buchappa Gongalla (6 out of 6 patents)

11. Srinivasa Krishna Murthy Konduri (5 out of 5 patents)

12. Venugopala Krishna Gampa (5 out of 5 patents)

13. Bollepalli Nageshwara Rao (4 out of 4 patents)

14. Janaki Rama Rao Ravi (3 out of 3 patents)

15. Uma Naresh Babu Kotra (3 out of 3 patents)

Core Competencies:

Sugammadex Sodium

Trifluridine

Ibrutinib

Cabozantinib

Ribociclib Succinate

Pomalidomide

Idelalisib

Dasatinib Polymorph

Ceritinib

Lenalidomide

Erlotinib Hydrochloride

Nilotinib

51 patents: Sort by Forward Citations

1. 12729197 - Process for the preparation of venetoclax and its polymorphs thereof (2026-09-08),

2. 12534467 - Process for the preparation of Acalabrutinib (2026-01-27),

3. 12522611 - Process for the preparation of high pure Eribulin and its Mesylate salt (2026-01-13),

4. 11845811 - Process for the preparation of Sugammadex sodium and its novel polymorphic form (2023-12-19),

5. 11730753 - Stable pharmaceutical compositions comprising trifluridine and tipiracil hydrochloride (2023-08-22),

6. 11576917 - Pharmaceutical compositions comprising Ibrutinib (2023-02-14),

7. 11498902 - Process for the preparation of Cabozantinib and its pharmaceutically acceptable salts thereof (2022-11-15),

8. 11465988 - Process for the preparation of Tipiracil hydrochloride and intermediates thereof (2022-10-11),

9. 11452722 - Stable pharmaceutical compositions comprising lenalidomide (2022-09-27),

10. 11414421 - Process for the preparation of ribociclib succinate and its novel crystalline forms thereof (2022-08-16),

11. 11111228 - Process for the preparation of pomalidomide and its purification (2021-09-07),

12. 11091470 - Process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochloride (2021-08-17),

13. 11008296 - Intermediates for the preparation of eribulin thereof (2021-05-18),

14. 10966971 - Pharmaceutical compositions of pomalidomide (2021-04-06),

15. 10870650 - Process for the preparation of amorphous idelalisib (2020-12-22),

Natco Pharma Limited is a publicly listed pharmaceutical company headquartered in India. Established in 1981, Natco specializes in the development, manufacturing, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company primarily focuses on oncology, hepatitis C, and other therapeutic segments. With a mission to provide affordable and accessible healthcare solutions, Natco has a strong global presence and exports its products to various countries. Their commitment to quality, innovation, and social responsibility have made them a trusted name in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Natco Pharma Limited

51 Patents

#4 in Hyderabad Telangana

#39 in India

#13,739 in the World

Hyderabad Telangana, India

Natco Pharma Limited

Forward Citations = 50

93 inventors:

Venkaiah Chowdary Nannapaneni (28 out of 28 patents)

Nannapaneni Venkaiah Chowdary (22 out of 22 patents)

Bhujanga Rao Adibhatla Kali Satya (16 out of 16 patents)

4. Durga Prasad Konakanchi (14 out of 15 patents)

5. Pulla Reddy Muddasani (12 out of 12 patents)

Please report any incorrect information to [email protected]

Loading…